The manufacturing agreement brings together PRF’s decades-long, research-driven Progeria program with Forge’s integrated gene therapy capabilities including process development, cGMP manufacturing, ...

Progeria, an ultrarare and fatal genetic disease characterized by rapid aging, can affect children and young adults.

Forge Biologics will provide process development and manufacturing services to support gene therapy for ultrarare disease Progeria ...

Last week, families of children and young adults with Progeria welcomed the news that we are one step closer to the first approved treatment for this ultra-rare, devastating condition that causes ...

Hutchinson–Gilford progeria syndrome is a rare disorder that impacts around 400 people in the world. Many people have heard of progeria because of its association with Benjamin Button - a fictional ...

Biologists tend not to discuss experimental results on a handful of cells and a single solitary mouse — too preliminary, too sketchy. David Liu of the Broad Institute therefore had no plans to present ...

Aging is a complex and natural process that affects all living organisms. As people age, normal biological processes are affecting, resulting in a decline in various organs and age-related conditions.

(Gray News) – The longest-living survivor of progeria has died at the age of 28. In a Facebook post, the Progeria Research Foundation announced that Sammy Basso passed away Saturday. “Sammy was the ...

Gene therapy increased lifespan 25 percent in a mouse model of the fatal accelerated aging disease progeria, Salk Institute scientists reported Monday. Using the powerful CRISPR gene editing ...

In the spring of 2005, families affected by progeria welcomed the news from two studies that uncovered new information about this rare, devastating condition that causes premature aging in children.